Validity of A Portable EKG Device to Monitor Heart Rate and Rhythm in College-aged Male Athletes

Main Article Content

Brenda Reeves
Priscilla Maghrabi
Brock Guetzke
Anna Howery

Keywords

sudden cardiac death, electrocardiogram, wearable technology

Abstract





Introduction: Sudden cardiac death (SCD) is the leading medical cause of death for male athletes, especially in anaerobic-based sports. Standard 12-lead electrocardiograms (STD-ECG) have received recent attention for their diagnostic utility, but lack the practicality for mass screenings. The purpose of this investigation was to assess the validity of a compact HD-EKG unit during various testing environments: rest, aerobic activity, and immediate recovery of anaerobic activity in college-age, male athletes. Methods: Twelve college-aged (19.9 ± 1.1 years old), male athletes volunteered. Test procedures included two ECG devices, a STD-ECG and a high-definition (HD-) EKG, simultaneously recording heart rate (HR) and rhythms during rest, a single-stage walking test, and during recovery of the Wingate Anaerobic Power test.


Results: Paired t-tests did not detect differences between measures of HR and rhythm (t(47) = -0.71, p > 0.05 and t(4) = 0.82, p > 0.05, respectively). The two measures of HR were very strongly related (r = 0.98, p < 0.001). However, the absolute difference between the STD-ECG and HD-EKG averaged 3.47 ± 4.44 bpm, which is significantly different than the acceptable variance of ± 2 bpm.


Conclusions: Wearable technology, such as a portable HD-EKG device worn during vigorous anaerobic activity, such as the Wingate Anaerobic Power test, may identify athletes most at risk for SCD.





Abstract 366 | PDF Downloads 215

References

1. Link MS, Estes NAM 3rd. Sudden cardiac death in the athlete: bridging the gaps between evidence, policy, and practice. Circulation. 2012;125(20):2511- 2516.
2. Harmon KG, Asif IM, Klossner D, Drezner JA. Incidence of sudden cardiac death in National Collegiate Athletic Association Athletes. Circulation. 2011;123(15):1594-1600.
3. Asif IM, Harmon KG. Incidence and etiology of sudden cardiac death: New updates for athletic departments. Sports Health. 2017;9(3):268-279.
4. Maron BJ, Thompson PD, Ackerman MJ, et al. Recommendations and considerations related to preparticipation screening for cardiovascular abnormalities in competitive athletes: 2007 update: a scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology Foundation. Circulation. 2007;115(12):1643-1455.
5. Harmon KG, Asif IM, Maleszewski JJ, et al. Incidence, cause, and comparative frequency of sudden cardiac death in National Collegiate Athletic Association Athletes: A decade in review. Circulation. 2015;132(1):10-19.
6. Sessa F, Anna V, Messina G, et al. Heart rate variability as predictive factor for sudden cardiac death. Aging . 2018;10(2):166-177.
7. Hillebrand S, Gast KB, de Mutsert R, et al. Heart rate variability and first cardiovascular event in populations without known cardiovascular disease: meta-analysis and dose-response meta-regression. Europace. 2013;15(5):742- 749.
8. Maranesi E, Morettini M, Agostinelli A, Giuliani C, Di Nardo F, Burattini L. Health monitoring in sport through wearable sensors: A novel approach based on heart-rate variability. In: Lecture Notes in Electrical Engineering. ; 2016:235-246.
9. ACSM. ACSM’s Guidelines for Exercise Testing and Prescription. Lippincott Williams & Wilkins; 2014.
10. Pickering TG, Hall JE, Appel LJ, et al. Recommendations for blood pressure measurement in humans: An AHA Scientific Statement from the Council on High Blood Pressure Research Professional and Public Education Subcommittee. J Clin Hypertens. 2005;7(2):102-109.
11. Jackson AS, Pollock ML. Practical assessment of body composition. Phys Sportsmed. 1985;13(5):76-90.
12. Lohmann TG, Roche AF, Martorell R. Anthropometric Standardization Reference Manual. Human Kinetics; 1988.
13. Heyward VH. Advanced Fitness Assessment and Exercise Prescription. Human Kinetics Publishers; 2010.
14. Mason RE, Likar I. A new system of multiple-lead exercise electrocardiography. Am Heart J. 1966;71(2):196-205.
15. Ebbeling CB, Ward A, Puleo EM, Widrick J, Rippe JM. Development of a single-stage submaximal treadmill walking test. Med Sci Sports Exerc. 1991;23(8):966-973.
16. Zupan MF, Arata AW, Dawson LH, Wile AL, Payn TL, Hannon ME. Wingate Anaerobic Test peak power and anaerobic capacity classifications for men and women intercollegiate athletes. J Strength Cond Res. 2009;23(9):2598-2604.
17. Bland JM, Martin Bland J, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Int J Nurs Stud. 2010;47(8):931-936.
18. Giles D, Draper N, Neil W. Validity of the Polar V800 heart rate monitor to measure RR intervals at rest. Eur J Appl Physiol. 2016;116(3):563-571.
19. Weippert M, Kumar M, Kreuzfeld S, Arndt D, Rieger A, Stoll R. Comparison of three mobile devices for measuring R-R intervals and heart rate variability: Polar S810i, Suunto t6 and an ambulatory ECG system. Eur J Appl Physiol. 2010;109(4):779-786.
20. Walsh JA 3rd, Topol EJ, Steinhubl SR. Novel wireless devices for cardiac monitoring. Circulation. 2014;130(7):573-581.
21. Kobayashi H. Effect of measurement duration on accuracy of pulse- counting. Ergonomics. 2013;56(12):1940-1944.
22. Lampert R. Evaluation and management of arrhythmia in the athletic patient. Prog Cardiovasc Dis. 2012;54(5):423-431.
23. Patel DA, Lavie CJ, Milani RV, Shah S, Gilliland Y. Clinical implications of left atrial enlargement: A review. Ochsner J. 2009;9(4):191-196.
24. Prior DL, La Gerche A. The athlete’s heart. Heart. 2012;98(12):947-955.
25. Rawshani DA. The ECG in left ventricular hypertrophy (LVH): criteria and implications – ECG learning. ECG learning. https://ecgwaves.com/ecg- left-ventricular-hypertrophy-lvh-clinical-characteristics/. Published April 4,
2017. Accessed August 4, 2018.